{
"NDC": {
"NDCCode": "67457-992-02",
"PackageDescription": "1 SYRINGE, GLASS in 1 CARTON (67457-992-02) / 2 mL in 1 SYRINGE, GLASS",
"NDC11Code": "67457-0992-02",
"ProductNDC": "67457-992",
"ProductTypeName": "HUMAN PRESCRIPTION DRUG",
"ProprietaryName": "Naloxone Hydrochloride",
"ProprietaryNameSuffix": null,
"NonProprietaryName": "Naloxone Hydrochloride",
"DosageFormName": "INJECTION, SOLUTION",
"RouteName": "INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS",
"StartMarketingDate": "20221202",
"EndMarketingDate": null,
"MarketingCategoryName": "ANDA",
"ApplicationNumber": "ANDA213843",
"LabelerName": "Mylan Institutional LLC",
"SubstanceName": "NALOXONE HYDROCHLORIDE",
"StrengthNumber": "1",
"StrengthUnit": "mg/mL",
"Pharm_Classes": "Opioid Antagonist [EPC], Opioid Antagonists [MoA]",
"DEASchedule": null,
"Status": "Active",
"LastUpdate": "2025-12-16",
"PackageNdcExcludeFlag": "N",
"ProductNdcExcludeFlag": "N",
"ListingRecordCertifiedThrough": "20261231",
"StartMarketingDatePackage": "20221202",
"EndMarketingDatePackage": null,
"SamplePackage": "N"
}
}